Five genetic variants associated with prostate cancer [4]

New England Journal of Medicine

Volumn 358, Issue 25, 2008, Pages 2738-2741

  Coates, Ralph J ^a   Khoury, Muin J ^a   Gwinn, Marta ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER RISK; CANCER SCREENING; DISEASE COURSE; GENETIC ASSOCIATION; GENETIC VARIABILITY; HUMAN; LETTER; PREDICTION; PRIORITY JOURNAL; PROSTATE CANCER; GENETIC MARKER; GENETIC PREDISPOSITION; GENETIC SCREENING; GENETICS; MALE; MARKETING; NOTE; PROSTATE TUMOR; METHODOLOGY; RISK FACTOR; ROC CURVE; SINGLE NUCLEOTIDE POLYMORPHISM; GENETIC POLYMORPHISM; GENETIC RISK;

GENETIC MARKERS; GENETIC PREDISPOSITION TO DISEASE; GENETIC SCREENING; HUMANS; MALE; MARKETING; PROSTATIC NEOPLASMS; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; ROC CURVE;

EID: 45549110226     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMc080680     Document Type: Letter

References (5)

1. Zheng SL, Sun J, Wiklund F, et al. Cumlative association of five genetic variants with prostate cancer. N Engl J Med 2008;358:910-9.
2. Kolata G. $300 to learn risk of cancer of the prostate. New York Times. January 17, 2008.
3. Khoury MJ, Gwinn M, Yoon PW, Dowling N, Moore CA, Bradley L. The continuum of translation research in genomic medicine: how can we accelerate the appropriate integration of human genome discoveries into health care and disease prevention? Genet Med 2007;9:665-74.
4. Nelen S. Epidemiology of prostate cancer. Recent Results Cancer Res 2007;175:1-8.
5. U.S. Preventive Services Task Force. Screening for prostate cancer: recommendations and rationale. Ann Intern Med 2002;137:915-6.